CervoMed
CRVO
48 hedge funds and large institutions have $20.9M invested in CervoMed in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 11 closing their positions.
504% more capital invested
Capital invested by funds: $3.46M → $20.9M (+$17.4M)
8.24% more ownership
Funds ownership: 18.01% → 26.24% (+8.2%)
0% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 14
9% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 11
2% less funds holding
Funds holding: 49 → 48 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
+$3.29M |
| 2 |
Morgan Stanley
New York
|
+$329K |
| 3 |
CFG
Citizens Financial Group
Providence,
Rhode Island
|
+$102K |
| 4 |
AAS
Avantax Advisory Services
Dallas,
Texas
|
+$99K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$94.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
-$175K |
| 2 |
PWM
Perigon Wealth Management
San Francisco,
California
|
-$170K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$139K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$65.6K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$51.4K |
CRVO Hedge Fund Activity: Q1 2025 in Review
48 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q1 2025, worth a combined $20.9M — up 504% from $3.46M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of CRVO and 10 opened new positions — a net loss of 1 holder — while 14 trimmed existing stakes and 14 added.
The largest buyer was AWM Investment Company, opening a new position worth an estimated $3.29M. The largest seller was Woodline Partners, exiting entirely with an estimated $175K sold.
- 48 institutional investors held CervoMed (CRVO) as of Q1 2025, down from 49 in Q4 2024.
- Funds reported $20.9M of CervoMed stock for Q1 2025, up 504% quarter-over-quarter.
- 10 funds opened new CervoMed positions in Q1 2025 and 11 closed out, a net change of -1 holder.
- The largest CervoMed buyer in Q1 2025 was AWM Investment Company, an estimated $3.29M added.
- The largest CervoMed seller in Q1 2025 was Woodline Partners, an estimated $175K sold.
Based on aggregated 13F filings for Q1 2025.